We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.02B
AUM Growth
-$1.32M
Cap. Flow
-$27.2M
Cap. Flow %
-2.65%
Top 10 Hldgs %
36.57%
Holding
447
New
77
Increased
110
Reduced
140
Closed
93

Top Buys

Rank Stock Value
1
EQNR icon
Equinor
EQNR
+$9.87M
2
MSFT icon
Microsoft
MSFT
+$9.79M
3
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$8.79M
4
ERF
Enerplus Corporation
ERF
+$6.71M
5
EXE
Expand Energy Corp
EXE
+$5.12M

Top Sells

Rank Stock Value
1
DEN
Denbury Inc.
DEN
+$28.4M
2
AR icon
Antero Resources
AR
+$22.5M
3
IMO icon
Imperial Oil
IMO
+$11.8M
4
ABBV icon
AbbVie
ABBV
+$9.22M
5
DAC icon
Danaos Corp
DAC
+$8.26M

Sector Composition

Rank Sector Weight
1 Energy 35.09%
2 Technology 13.02%
3 Healthcare 11.46%
4 Industrials 9.72%
5 Financials 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIEW
326
DELISTED
View, Inc. Class A Common Stock
VIEW
$87K 0.01%
+1,081
New +$123K
LVLU icon
327
Lulu's Fashion Lounge
LVLU
$55M
$75K 0.01%
+1,074
New +$117K
NOTE.WS
328
DELISTED
FiscalNote Holdings Warrants
NOTE.WS
$49K ﹤0.01%
+57,000
New +$53.7K
PIIIW icon
329
P3 Health Partners Inc Warrant
PIIIW
$136K
$49K ﹤0.01%
65,835
-1,517
-2% -$1.09K
WALDW icon
330
Waldencast PLC Warrant
WALDW
$4.48M
$48K ﹤0.01%
64,000
-1,500
-2% -$1.21K
MIR.WS
331
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
$41K ﹤0.01%
27,500
– –
BTMDW
332
DELISTED
Biote Corp. Warrant
BTMDW
$39K ﹤0.01%
115,181
+21,178
+23% +$6.87K
ME
333
DELISTED
23andMe Holding Co
ME
$36K ﹤0.01%
+634
New +$41.5K
PEARW
334
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$35K ﹤0.01%
207,891
-5,660
-3% -$830
DCRDW
335
DELISTED
Decarbonization Plus Acquisition Corporation IV Warrant
DCRDW
$31K ﹤0.01%
57,000
-1,000
-2% -$212
EOCW.WS
336
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$19K ﹤0.01%
117,895
-17,390
-13% -$4.33K
HCVIW
337
DELISTED
Hennessy Capital Investment Corp. VI Warrant
HCVIW
$18K ﹤0.01%
118,560
-37,904
-24% -$7.45K
ATEK.WS
338
DELISTED
Athena Technology Acquisition Corp. II Redeemable Warrants
ATEK.WS
$18K ﹤0.01%
153,585
-33,065
-18% -$4.55K
SVFAW
339
DELISTED
SVF Investment Corp. Warrant
SVFAW
$18K ﹤0.01%
105,500
– –
KAHC.WS
340
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
$15K ﹤0.01%
128,515
-4,020
-3% -$837
ROSS.WS
341
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$13K ﹤0.01%
171,150
-6,738
-4% -$846
CBRGW
342
DELISTED
Chain Bridge I Warrants
CBRGW
$12K ﹤0.01%
89,165
-16,845
-16% -$2.47K
ALLG.WS
343
DELISTED
Allego N.V. Warrants
ALLG.WS
$9K ﹤0.01%
19,500
-10,175
-34% -$4.27K
FMIVW
344
DELISTED
Forum Merger IV Corporation Warrant
FMIVW
$8K ﹤0.01%
130,962
-4,100
-3% -$556
NETC.WS
345
DELISTED
Nabors Energy Transition Corp. Warrants, exercisable for one share of Class A Common Stock
NETC.WS
$6K ﹤0.01%
40,160
-3,530
-8% -$629
ACAQ.WS
346
DELISTED
Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
ACAQ.WS
$4K ﹤0.01%
82,000
-10,685
-12% -$1.52K
CZOO.WS
347
DELISTED
Cazoo Group Ltd Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CZOO.WS
$4K ﹤0.01%
77,500
– –
CRHC.WS
348
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
$4K ﹤0.01%
179,474
-37,399
-17% -$18.1K
NAACW
349
DELISTED
North Atlantic Acquisition Corporation Warrant
NAACW
$3K ﹤0.01%
60,493
-21,220
-26% -$1.08K
BPACW
350
DELISTED
Bullpen Parlay Acquisition Company Warrant
BPACW
$2K ﹤0.01%
29,805
-5,045
-14% -$454
12 13
14
15 16

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return

Advisory Research's Q3 2022 Portfolio in Review

As of Q3 2022, Advisory Research held 447 positions worth $1.02B, down 0.13% from $1.02B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Advisory Research's Q3 2022 filing shows 77 new, 110 increased, 140 reduced and 93 closed positions. Its largest new stake was Velo3D, Inc.: 38,954 shares worth $5.37M. The largest sale was Denbury Inc., an estimated $28.4M.

By sector, the portfolio is most concentrated in Energy at 35% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.

  • Advisory Research's largest Q3 2022 buy was Velo3D, Inc.: 38,954 shares worth $5.37M.
  • Advisory Research added most to Equinor in Q3 2022, an estimated $9.87M increase.
  • Advisory Research's biggest Q3 2022 reduction was Denbury Inc., cutting an estimated $28.4M.
  • Advisory Research fully exited Imperial Oil in Q3 2022, selling an estimated $11.8M.
  • Advisory Research's ten largest holdings make up 37% of its $1.02B portfolio in Q3 2022.
  • Advisory Research opened 77 new positions and closed 93 in Q3 2022.
  • Advisory Research's portfolio value fell 0.13% quarter-over-quarter to $1.02B.

Based on Advisory Research's 13F filing for Q3 2022, filed 15 Nov 2022.